<SEC-DOCUMENT>0001401914-20-000050-index.html : 20200422
<SEC-HEADER>0001401914-20-000050.hdr.sgml : 20200422
<ACCEPTANCE-DATETIME>20200422161752
ACCESSION NUMBER:		0001401914-20-000050
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200422
DATE AS OF CHANGE:		20200422
EFFECTIVENESS DATE:		20200422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dare Bioscience, Inc.
		CENTRAL INDEX KEY:			0001401914
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				204139823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36395
		FILM NUMBER:		20808133

	BUSINESS ADDRESS:	
		STREET 1:		3655 NOBEL DRIVE
		STREET 2:		SUITE 260
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-926-7655

	MAIL ADDRESS:	
		STREET 1:		3655 NOBEL DRIVE
		STREET 2:		SUITE 260
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cerulean Pharma Inc.
		DATE OF NAME CHANGE:	20090714

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tempo Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070604
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14aproxyadditionalmate.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: defa14aproxyadditionalmate.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>additionalproxymaterials001.jpg
<TEXT>
Document 2 - file: additionalproxymaterials001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>additionalproxymaterials002.jpg
<TEXT>
Document 3 - file: additionalproxymaterials002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>additionalproxymaterials003.jpg
<TEXT>
Document 4 - file: additionalproxymaterials003.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>additionalproxymaterials004.jpg
<TEXT>
Document 5 - file: additionalproxymaterials004.jpg

</DOCUMENT>
</SEC-DOCUMENT>